Metabolic syndrome and high-sensitivity C-reactive protein co-modify the risk of coronary artery calcification.

Checking your browser before accessing pmc.ncbi.nlm.nih.gov ... Click here if you are not automatically redirected after 5 seconds.

Related documents

• Natriuretic peptide receptor C in cardiovascular-kidney-liver-metabolic syndrome: from natriuretic peptide deficiency to direct tissue signaling?#1107577
• Study of Lipid Profile of Patients With Chronic Coronary Syndromes at Sohag University Hospital#1161383
• Development and validation of the C-reactive protein–triglyceride-glucose index for predicting short- and long-term mortality in critically ill patients with coronary artery disease: a multicenter cohort study.#239754
• Emerging quantitative CCTA imaging biomarkers for cardiovascular risk stratification: a narrative review.#469165
• Effects of Coenzyme Q10 Supplement on Cardiovascular Risk Factors in Subjects at High Risk of Metabolic Syndrome#1102138